Omission of adjuvant therapy in stage I clear cell ovarian cancer: Review of the BC Cancer experience

BACKGROUND: Since 2012, the BC Cancer provincial treatment guideline for surgically staged stage IA/B and IC1 (defined by intraoperative rupture only) clear cell ovarian cancer (CCOC) has been to offer observation only. We reviewed the clinical outcomes of all stage I CCOC patients since policy impl...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shiru L., Tinker, Anna V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965725/
https://www.ncbi.nlm.nih.gov/pubmed/31970284
http://dx.doi.org/10.1016/j.gore.2019.100533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965725/
https://www.ncbi.nlm.nih.gov/pubmed/31970284
http://dx.doi.org/10.1016/j.gore.2019.100533

Ejemplares similares